Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             160 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A coffee enriched with guarana, selenium, and l-carnitine (GSC) has nutrigenomic effects on oxi-inflammatory markers of relapsing-remitting multiple sclerosis patients: A pilot study Teixeira, Cibele Ferreira

71 C p.
artikel
2 Adherence to Disease Modifying Treatment Among Multiple Sclerosis Patients from Upper Egypt Khedr, Eman M

71 C p.
artikel
3 Adherence to Treatment in Multiple Sclerosis Yahyaoui, Ichrak

71 C p.
artikel
4 Aggressive Pediatric Multiple Sclerosis: Features and therapeutic Challenges Gharsallah, Farah

71 C p.
artikel
5 A qualitative exploration of the rehabilitation perceptions and experiences of persons with early multiple sclerosis Brusola, Gregory

71 C p.
artikel
6 Area Postrema Syndrome in Neuromyelitis Optica Spectrum Disorder: Diagnostic Challenges and Descriptive Patterns Khedr, Eman M.

71 C p.
artikel
7 A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapies Stoll, Sharon

71 C p.
artikel
8 Assessment of the Pathological Fatigue in Patients with Multiple Sclerosis in Morocco. Lotfi, Rachid

71 C p.
artikel
9 Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort de Ruiter, Lodewijk R.J.

71 C p.
artikel
10 Atypical Cerebral MRI Imaging Associated Related to NMOSD Saaf, Sarra

71 C p.
artikel
11 A Unique Case of Radiologically Isolated Syndrome Diagnosed during a Follow-Up of Cytomegalovirus Meningoencephalitis Sara, Lhassani

71 C p.
artikel
12 Autonomic Disorders in Multiple Sclerosis Souissi, Amira

71 C p.
artikel
13 BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis Bruno, Antonio

71 C p.
artikel
14 Barriers to Access Multiple Sclerosis Disease-Modifying therapies in Middle East and North Africa: A Regional Survey-Based Study Zeineddine, Maya

71 C p.
artikel
15 Barriers to Engage in Physical Activity in People with Multiple Sclerosis in Jordan Khalil, Hanan

71 C p.
artikel
16 Bio-Psycho-Social Model of Multiple Sclerosis (BPSMMS) El-Bilsha, Mona Ahmed

71 C p.
artikel
17 Central Nervous System Disease in Primary Sjögren's Syndrome Fekih, Mariem El

71 C p.
artikel
18 Ceramide is implicated in humoral peripheral and intrathecal autoimmune response in MS patients Podbielska, Maria

71 C p.
artikel
19 Changes in physiotherapy services and use of technology for people with multiple sclerosis during the COVID-19 pandemic Jonsdottir, Johanna

71 C p.
artikel
20 Cigarette, Water-Pipe and Drug Substance Abuse Smoking and the Risk of Primary Progressive Multiple Sclerosis Eskandarieh, Sharareh

71 C p.
artikel
21 Clinical and MRI Correlates of Antinuclear Antibodies in Multiple Sclerosis Patients Rim, Smaoui

71 C p.
artikel
22 Clinical and Radiological Aspects of Acute Disseminated Encephalomyelitis-Like Manifestations in Children Hafsa, Meriem Ben

71 C p.
artikel
23 Clinical Predictors of Transation to Secondary Progressive Multiple Sclerosis Shalaby, Nevin M

71 C p.
artikel
24 CNS Complications Following COVID-19 Vaccines: an Egyptian Case Series. Salama, Sara

71 C p.
artikel
25 Cognitive Dysfunction: The Dark Side of the Moon Khermache, Ali

71 C p.
artikel
26 Cognitive rehabilitation and mindfulness reduce cognitive complaints in multiple sclerosis (REMIND-MS): A randomized controlled trial Nauta, Ilse M.

71 C p.
artikel
27 Comparative efficacy and safety of ozanimod and ponesimod for relapsing multiple sclerosis: A matching-adjusted indirect comparison Swallow, Elyse

71 C p.
artikel
28 Concurrent diagnoses of Tuberous sclerosis and multiple sclerosis Quigley, Suzanne

71 C p.
artikel
29 Consultation in Patients with Multiple Sclerosis Heidari, Hora

71 C p.
artikel
30 Cost, efficacy, and safety comparison between early intensive and escalating strategies for multiple sclerosis: A systematic review and meta-analysis Pipek, Leonardo Zumerkorn

71 C p.
artikel
31 Cross-Cultural Adaptation and Psychometric Evaluation of the Physical Activity and Disability Survey - Revised in People with Multiple Sclerosis Al-Sharman, Alham

71 C p.
artikel
32 Current and Future Trends in MS Management: Near East Perspective Sahrian, Mohammad Ali

71 C p.
artikel
33 Differentiating Acute Infectious and Post-Infectious Cerebellitis: A Tunisian Pediatric Case Series Jamoussi, Maha

71 C p.
artikel
34 Discrepancies between self-report and objective sleep outcomes are associated with cognitive impairment and fatigue in people with multiple sclerosis and insomnia Opelt, Brett L.

71 C p.
artikel
35 Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of COVID-19 in Multiple Sclerosis: A MENACTRIMS Registry Based Study Zeineddine, Maya

71 C p.
artikel
36 Early onset of Action and Sustained Efficacy of MRI Outcomes during Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-Year MAGNIFY-MS Study De Stefano, Nicola

71 C p.
artikel
37 Effectiveness and safety of switching from fingolimod and natalizumab to rituximab in patients with relapsing remitting multiple sclerosis Fakih, Ali Ussama

71 C p.
artikel
38 Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study Barzegar, Mahdi

71 C p.
artikel
39 Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective study Abuaf, Amanda Frisosky

71 C p.
artikel
40 Effectiveness & Safety Profile of Fingolimod in Treating Omani Patients with Multiple Sclerosis, Single Tertiary Center Experience Al-Asmi, Abdullah

71 C p.
artikel
41 Effect of deep gray matter atrophy on information processing speed in early relapsing-remitting multiple sclerosis Naghavi, Saba

71 C p.
artikel
42 Effects of constraint induced movement therapy in patients with multiple sclerosis: A systematic review Abdullahi, Auwal

71 C p.
artikel
43 Efficacy of Virtual Reality Interventions on Mood and Cognition in Patients with Multiple Sclerosis. a Systematic Review Shahien, Mostafa

71 C p.
artikel
44 Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosis Dillon, Paul

71 C p.
artikel
45 Epidemiological Parameters of Multiple Sclerosis in Chaharmahal- Bakhtiari Province, Iran Omrani, Mohammad Amin

71 C p.
artikel
46 Epidemiological Study of Multiple Sclerosis Patients in Iran, a Comparative Approach Based on Gender and Time. Mehdipour, Roshanak

71 C p.
artikel
47 Epidemiology of multiple sclerosis in the Campania Region (Italy): Derivation and validation of an algorithm to calculate the 2015-2020 incidence Affinito, Giuseppina

71 C p.
artikel
48 Evaluation of Intelligence Quotient (IQ) in Patients with Neuromyelitis Optica Spectrum Disease and Multiple Sclerosis Barzegar, Mahdi

71 C p.
artikel
49 Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, Decreases Neurofilament Light Chain Levels Over 2.5 Years of Treatment in Patients with Relapsing Multiple Sclerosis Kuhle, Jens

71 C p.
artikel
50 Evolution of the Rebismart® Autoinjector Device to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a therapy for Relapsing Multiple Sclerosis Lin, Yu-Ting

71 C p.
artikel
51 Expert Consensus to Develop a Questionnaire for Defining the Activity of Relapsing Remitting Multiple Sclerosis in Egypt Zakaria, Magd

71 C p.
artikel
52 Expert Opinion on Long-Term Use of Cladribine Tablets for Multiple Sclerosis: Systematic Literature Review of Real-World Evidence Oreja-Guevara, Celia

71 C p.
artikel
53 Exploring the Relationship Between Serum GDF-15 and Disease Stability in Patients with a First Clinical Demyelinating Event Treated with Subcutaneous Interferon Β-1a Or Placebo in the REFLEX Study Coray, Mali

71 C p.
artikel
54 Extracellular vesicles as contributors in the pathogenesis of multiple sclerosis Zamboni, Silvia

71 C p.
artikel
55 Fatigue and Regional White Matter Lesion Load in Relapsing Remitting Multiple Sclerosis Ezzeldin, Mohammed Yosri

71 C p.
artikel
56 Fatigue in Patients with Multiple Sclerosis in an Algeria Cohort Khermache, Ali

71 C p.
artikel
57 Feasibility and usability of a new home-based immersive virtual reality headset-based dexterity training in multiple sclerosis Kamm, Christian P

71 C p.
artikel
58 2 grams versus 1 gram rituximab as maintenance schedule in multiple sclerosis, neuromyelitis optica spectrum disorders and related diseases: What B-cell repopulation data tell us Rual, Celso

71 C p.
artikel
59 Healthcare complexities during community crises: Recommendation for access to healthcare for Australians with multiple sclerosis Learmonth, Yvonne C.

71 C p.
artikel
60 High Adherence and Minimal Delays of Year 2 Treatment in People with Multiple Sclerosis Treated with Cladribine Tablets: Results from Multi-Country Patient Support Programmes Oh, Jiwon

71 C p.
artikel
61 Horizontal Switching of therapies with Moderate Efficacy in Newly Treated People with Multiple Sclerosis in Greece Bakirtzis, Christos

71 C p.
artikel
62 Immunomodulatory Potential of Anti-IFN-Beta Antibodies on Monocyte Derived Macrophages Sominanda, Ajith

71 C p.
artikel
63 Impact of COVID-19 on prescribing patterns and treatment selection of disease modifying therapies in multiple sclerosis Zaheer, Reemal

71 C p.
artikel
64 Impact of Dyslipidemia on Progression of Multiple Sclerosis Zoubi, Souad Ahmad

71 C p.
artikel
65 Impact of Gradual Tapering Strategy of Fingolimod on Recurrence of Disease Activity in Patients with Multiple Sclerosis Elshebawy, Haidy

71 C p.
artikel
66 Impact of Multiple Sclerosis First Relapse on Disease History: Reports of a Tunisian Cohort Souissi, Amira

71 C p.
artikel
67 Improvements in Quality of Life Over 2 Years in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: Final Analysis of CLARIFY-MS Solari, Alessandra

71 C p.
artikel
68 Initial Clinical and Radiological Manifestation of Multiple Sclerosis Patients in Neurology Department in Gabes Hospital in Tunisia Dorgham, Dorra

71 C p.
artikel
69 In-person and remote administrations of the symbol digit modalities test are interchangeable among persons with multiple sclerosis Levy, Sarah

71 C p.
artikel
70 Involvement Peripheral Nerve System in Multiple Sclerosis Oudrer, Naima

71 C p.
artikel
71 Is Body Mass Index (BMI) Associated with Risk and Outcomes of COVID-19 in Iranian Multiple Sclerosis Patients? Rezaeimanesh, Nasim

71 C p.
artikel
72 Is there a Link Between Multiple Sclerosis and Pregnancy in Terms of Tendency, Reproductive Characteristics, and Disability? a Secondary Data Analysis of Nationwide MS Registry of Iran Eskandarieh, Sharareh

71 C p.
artikel
73 Is there Any Association Between Physical Activity and Body Mass Index with Fatigue and Anxiety in Patients with Relapsing Remitting Multiple Sclerosis? Rezaeimanesh, Nasim

71 C p.
artikel
74 “It's on the tip of my tongue!” exploring confrontation naming difficulties in patients with multiple sclerosis Grezmak, Tiffany

71 C p.
artikel
75 Kynurenines Metabolites as Biomarkers for Progression in Multiple Sclerosis Fahmi, Rasha Mohamed

71 C p.
artikel
76 Leber Hereditary Optic Neuropathy Presenting as Bilateral Visual Loss and White Matter Disease Shirah, Bader Hamza

71 C p.
artikel
77 Life Quality and Work Productivity in Multiple Sclerosis Among a Tunisian Population Rim, Smaoui

71 C p.
artikel
78 Lifestyle and Environmental Factors in Multiple Sclerosis Rim, Smaoui

71 C p.
artikel
79 Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis Tsagkas, Charidimos

71 C p.
artikel
80 Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging Shi, Zhuowei

71 C p.
artikel
81 MOG-Associated Disease: Clinical and Paraclinical Study of a Tunisian Pediatric Series Miladi, Zouhour

71 C p.
artikel
82 MRI and Clinical Outcomes of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, in Relapsing Multiple Sclerosis Over 2.5 Years of the Open-Label Extension to a Phase 2 Trial Vermersch, Patrick

71 C p.
artikel
83 Multiple Sclerosis Diagnostic Delay and Its Associated Factors in Upper Egyptian Patients Khedr, Eman M

71 C p.
artikel
84 Multiple Sclerosis in Children: Case Report Ichrak, Yahiaoui

71 C p.
artikel
85 Multiple Sclerosis in Middle East North Africa (MENA) Region: Challenges, Achievements and Opportunities. Hassan, Amr

71 C p.
artikel
86 Multiple Sclerosis Patients’ Perception of Traditional and Complementary Medicine Harbi, Awad Al

71 C p.
artikel
87 Multiple Sclerosis Prodrome in 23 MS Patients Naoures, Issaoui

71 C p.
artikel
88 Myopia in late adolescence and subsequent multiple sclerosis among men Hiyoshi, Ayako

71 C p.
artikel
89 Neuromyelitis Optica Spectrum Disorders Mimicking Wernicke's Encephalopathy: Difficult Differential Diagnosis Shirah, Bader Hamza

71 C p.
artikel
90 Neuromyelitis Optica Spectrum Disorders Presenting as Cardiopulmonary Arrest Shirah, Bader Hamza

71 C p.
artikel
91 Neuropathologically informed imaging of cortical grey matter lesions in MS – A pilot study Quigley, S

71 C p.
artikel
92 Neutrophil to lymphocyte ratio may be a useful marker in distinguishing MOGAD and MS and platelet to lymphocyte ratio associated with MOGAD activity Lin, Liuyu

71 C p.
artikel
93 New B Cell-Related Markers in MS Diagnosis: The Tunisian Experience Feki, Sawsan

71 C p.
artikel
94 Nurses' Knowledges on Multiple Sclerosis Disease in the Béni-Mellal Khénifra Region, Morocco Lotfi, Rachid

71 C p.
artikel
95 Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: A three decade study Moghtaderi, Ali

71 C p.
artikel
96 Outcomes of Pregnancy in Egyptian Women with Multiple Sclerosis in the New Treatment Era: A Multi-Center Retrospective Observational Study. Ahmed, Ali Mahmoud

71 C p.
artikel
97 Pain and cognitive performance in adults with multiple sclerosis: A systematic review Brown, Fraser S

71 C p.
artikel
98 Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes Theodorsdottir, A

71 C p.
artikel
99 Personalized Half-Dose Ocrelizumab in Selected Patients with Relapsing-Remitting Multiple Sclerosis Shirah, Bader Hamza

71 C p.
artikel
100 Predictive factors of multiple sclerosis relapse after the first demyelinating event: A 5-year follow-up Kolčava, Jan

71 C p.
artikel
101 Predictors of hospitalization due to infection in rituximab-treated MS patients Karlowicz, Jakob Rishovd

71 C p.
artikel
102 Pregnancy and Fetal Outcomes in Omani Women with Multiple Sclerosis, Single Tertiary Center Experience Al-Asmi, Abdullah

71 C p.
artikel
103 Prevalence and Incidence of Multiple Sclerosis in Isfahan Province, Iran: A 25-Year Population-Based Study Bagherieh, Sara

71 C p.
artikel
104 Prevalence of Restless Leg Syndrome and Its Effects on Quality of Sleep in Sample of MS Saudi Population Aljuaid, Hanouf

71 C p.
artikel
105 Primary Antiphospholipid Antibody Syndrome Mimicking a Progressive MS: Case Report Naoures, Issaoui

71 C p.
artikel
106 Psychotherapy and professional psychological support in multiple sclerosis: Uncovering patients’ patterns of access and preferences Morris-Bankole, Hannah

71 C p.
artikel
107 Quality of life, Knowledge and Access to Treatment in Times of Economic crisis in Lebanon Ismail, Ghida

71 C p.
artikel
108 Quantifying the economic burden to patients of relapse events from neuromyelitis optica spectrum disorders: A cross-sectional survey Rice, Dylan R.

71 C p.
artikel
109 Radiological Markers Capable of Differentiating Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorder; a Systematic Review and Meta-Analysis Bagherieh, Sara

71 C p.
artikel
110 Rate of Parental Consanguineous Marriage Among Familial Multiple Sclerosis Patients in Iran: A National Registry-Based Study Eskandarieh, Sharareh

71 C p.
artikel
111 Real-Life Study with Alemtuzumab, Kuwait Experience Alroughani, Raed

71 C p.
artikel
112 Real-Life Study with Cladribine: Kuwait Experience Ahmed, Samar Farouk

71 C p.
artikel
113 Real World Experience for Clad T in the Management of Relapsing Multiple Sclerosis in the United Arab Emirates Inshasi, Jihad Said

71 C p.
artikel
114 Real-World Experience on the Use of COVID-19 Vaccination in Multiple Sclerosis Patients Treated with Cladribine Tablets Participating in the ADVEVA® Patient Support Program within the Gulf and Latin American Regions Rodas, María Isabel Zuluaga

71 C p.
artikel
115 Real-World Use of Cladribine Tablets (Completion Rates and Treatment Persistence) in Patients with Multiple Sclerosis in England: the CLARENCE Study Brownlee, Wallace

71 C p.
artikel
116 Relationship Between Disability and Psychiatric Outcome in Multiple Sclerosis Patients and Its Determinants Hassan, Shady Safwat

71 C p.
artikel
117 Reliability and Validity of the Arabic Version of Brief International Cognitive Assessment for Multiple Sclerosis in Egyptian Pediatric Multiple Sclerosis Patient Ibrahim, Ebtehal Sayed

71 C p.
artikel
118 Reliability and Validity of the Arabic Version of Brief International Cognitive Assessment for Multiple Sclerosis in Egyptian Pediatric Multiple Sclerosis Patients Ibrahim, Ebtehal Sayed

71 C p.
artikel
119 RION Vs CRION: The Roadmap Merghany, Nahla

71 C p.
artikel
120 Role of Type 1 Interferons therapy on Adverse Clinical Outcomes on COVID-19 in Hospitalized Multiple Sclerosis Patients Maghbooli, Zhila

71 C p.
artikel
121 Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot study Yalachkov, Yavor

71 C p.
artikel
122 Serum Glutamate as a Biomarker in NMO and MS Rabah, Amany Mahmoud

71 C p.
artikel
123 Serum Level of Brain-Derived Neurotrophic Factor in Patients with Relapsing Remitting Multiple Sclerosis: A Potential Biomarker for Disease Activity Oraby, Mohammed Ibrahim

71 C p.
artikel
124 Sexual Dysfunction during Multiple Sclerosis Imed, Mtar

71 C p.
artikel
125 Sexual Dysfunctions and Self-Esteem in Multiple Sclerosis: A Tunisian Study Rihab, Charfi

71 C p.
artikel
126 Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort Bhise, Vikram

71 C p.
artikel
127 Sleep Disorders in Relapsing-Remitting Multiple Sclerosis Patients Mnif, Senda

71 C p.
artikel
128 Sleep Disorders in Tunisian Patients with Multiple Sclerosis Mnif, Maha

71 C p.
artikel
129 Smart Wearable Assistive Device for Multiple Sclerosis Patients with Impaired Deep Sensation Azm, Abeer Saber Aboul

71 C p.
artikel
130 Social and Environmental Triggers of Multiple Sclerosis onset: A Retrospective Study from Iran Abbasi, Naghmeh

71 C p.
artikel
131 Specific alterations in NKG2D+ T lymphocytes in relapsing-remitting and progressive multiple sclerosis patients Carmena Moratalla, Ana

71 C p.
artikel
132 Status of Cerebrospinal Fluid Oligoclonal Bands Among Patients with Multiple Sclerosis MS at King Abdulaziz Medical City Alamri, Noof M

71 C p.
artikel
133 Steroid-induced weight gain in the treatment of neurosarcoidosis Lackey, Elijah

71 C p.
artikel
134 Telerehabilitation versus virtual reality supported task-oriented circuit therapy on upper limbs and trunk functions in patients with multiple sclerosis: A randomized controlled study Doğan, Mert

71 C p.
artikel
135 Ten Years Natural History of Multiple Sclerosis in Kuwait Population Alroughani, Raed

71 C p.
artikel
136 The Association Between Dietary Galactose Intake and Risk of Concomitant Diseases Among Patients with Neuromyelitis Optica Spectrum Disorder Rezaeimanesh, Nasim

71 C p.
artikel
137 The Clinical Course of Multiple Sclerosis Patients in Oran Oudrer, Naima

71 C p.
artikel
138 The Cost-Effectiveness Analysis of Ozanimod in Comparison to Fingolimod in Iran Ayati, Nayyereh

71 C p.
artikel
139 The effectiveness of nontraditional or home-based programing on ADL performance of individuals living with multiple sclerosis: A systematic review Belveal, Kimberlyn

71 C p.
artikel
140 The effect of Transcutaneous Electrical Nerve Stimulation (TENS) and Interferential Currents (IFC) on pain, functional capacity, and quality of life in patients with multiple sclerosis: A randomized controlled, single-blinded study. Katirci Kirmaci, Zekiye İpek

71 C p.
artikel
141 The Frequency of Lymphopenia in Omani Multiple Sclerosis Patients Treated with Dimethyl Fumarate at Sultan Qaboos University Hospital Al-Asmi, Abdullah

71 C p.
artikel
142 The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis Kumar, Nitish

71 C p.
artikel
143 The Longitudinal Study of Neuromyelitis Optica Spectrum Patients Epidemiological Characteristics, a Six Years Follow Up Survey from Isfahan, Iran. Mehdipour, Roshanak

71 C p.
artikel
144 Therapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America Rojas, Juan Ignacio

71 C p.
artikel
145 The Rate and Pattern of Changes in MS Disease Modifying Drugs in Tehran, Iran; a Cross-Sectional Study from Tehran MS Registry Eskandarieh, Sharareh

71 C p.
artikel
146 The Relationship Between Adherence to the Mediterranean Diet with Anthropometric Items, Comorbidities, and Disability Scale in Patients with Multiple Sclerosis Sharifi, Mohammad Hossein

71 C p.
artikel
147 The uncertainty period preceding the clinical defined SPMS diagnosis and the applicability of objective classifiers – A Danish single center study Holm, Rolf Pringler

71 C p.
artikel
148 The Use of Complementary Medicine for Patients with Multiple Sclerosis in Morocco Lotfi, Rachid

71 C p.
artikel
149 The Use of Ocrelizumab in Pediatric Multiple Sclerosis Patients in the United Arab Emirates: A Retrospective Study Atieh, Mutaz Iyad

71 C p.
artikel
150 The Use of Rituximab in the Treatment of Multiple Sclerosis in Morrocco Siham, Asri

71 C p.
artikel
151 Tixagevimab and Cilgavimab (Evusheld) Boosts Antibody Levels to SARS-Cov-2 in Patients with Multiple Sclerosis on B-Cell Depleters Conte, William L.

71 C p.
artikel
152 Tobacco Smoke and Sleep Quality Among People with Multiple Sclerosis: A Comparison Study Aldughmi, Mayis

71 C p.
artikel
153 Tumefactive Balo-Like Concentric Sclerosis in Treatment with Fingolimod Baghbanian, Seyed Mohammad

71 C p.
artikel
154 Uncovering Nurses' and Patients' Preferences and Perceptions of Rebismart® 3.0 Autoinjector Versus Other Assistive Devices in Multiple Sclerosis Colten, Sridevi

71 C p.
artikel
155 Use of Social Media Tools during COVID-19 Pandemic Among MS Fellowships and Patients Mokhberdezfuli, Mahdieh

71 C p.
artikel
156 Validity of the 30-Second Sit-to-Stand test as a measure of lower extremity function in persons with multiple sclerosis: Preliminary evidence Zheng, Peixuan

71 C p.
artikel
157 Vascular function and cognition in persons with multiple sclerosis: Preliminary examination Zheng, Peixuan

71 C p.
artikel
158 Vitamin D-Related Parameters and Th17 Pathway in Multiple Sclerosis: A Serological, Transcriptomic and Functional Study Feki, Sawsan

71 C p.
artikel
159 What If It Is not Optic Neuritis? Megherbi, Lilia

71 C p.
artikel
160 White Matter Lesion Load and Location in Relation to Cognitive and Physical Dysfunctions in Relapsing Remitting Multiple Sclerosis Ezzeldin, Mohammed Yosri

71 C p.
artikel
                             160 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland